G7 Product Training

DME Partners

CONFIDENTIAL – DO NOT DISTRIBUTE

Dexcom saved Lyla’s life last night. Its alarms got me up. She
was out cold. I woke her and gave her soda. Still low. More soda.
Still low. Spoonfuls of sugar. Finally, movement! We stayed up
together for nearly an hour like this and she barely even came
back into range. That tells me she wasn’t just low. She would
have died. I’m in tears feeling how close I came to losing my little
girl… but those are tears of gratitude rather than mourning
because of that amazing little device. Words are utterly
inadequate but thank you to everyone at Dexcom for keeping my
daughter alive.”

Lyla G’s Dad

2
G7 Product Training
DME Partners

Kevin Rogers & Christine Luby

CONFIDENTIAL – DO NOT DISTRIBUTE

Agenda

Introduction
01
Dexcom | Diabetes | CGM

G7 Product
02
Indications | Sensor | Receiver & Apps

Accuracy & Comparisons

03 MARD | G6 | Libre 2 & 3

Q&A
04

4
Introduction
Dexcom | Diabetes | CGM
Dexcom History
Empowering People To Take Control Of Health

Founded: 1999
Headquarters: San Diego, CA
Manufacturing: San Diego, CA / Mesa, AZ / Malaysia (2023)
U.S. Field Sales: 250+ Representatives Covering All 50 States

7
Dexcom Product Launches

2006 2007 2009 2012 2015 2018 2023

First Generation CGM Dexcom SEVEN Dexcom SEVEN Dexcom G4 Dexcom G5 Dexcom G6 Dexcom G7
(STS).Launched System Launched PLUS System PLATINUM System Mobile System System Launched System Launched
Launched Launched Launched

8
Other Important Dates

2016 2017 2020 2022 2023

FDA Approves the Non- Dexcom G5 Approved Under Dexcom G6 Integrated With Dexcom G6 Integrated With New CMS guidelines take
Adjunctive Label for the Medicare Tandem Insulin Pump Omnipod 5 (Insulet) Insulin effect that broaden access to
Dexcom G5 Pump CGM

9
Diabetes
Diabetes: An Insidious Disease
Type 1
• Autoimmune
• Treated with insulin

Type 2
• Complex
• Multiple treatment modalities

Gestational (During Pregnancy)

• High risk to both mom and baby
11
The Role of Insulin

12
Multiple guidelines now recommend CGM for all patients on insulin

GUIDELINES RECOMMENDATIONS
Diabetes Technology: CGM is recommended for adults with diabetes
Standards of Medical
Care in Diabetes • On multiple daily insulin injections (MDI) or continuous subcutaneous insulin infusion (CSII) (Grade A)
(2022)1,* • On basal insulin capable of safely using devices by themselves or with a caregiver (Grade A)

The Use of Advanced • CGM is strongly recommended for all patients with diabetes treated with MDI or an insulin pump
Technology in the (Grade A)
Management of Persons
With Diabetes Mellitus • CGM may be recommended for individuals with T2D who are treated with less intensive insulin therapy
(2021)2 (Grade B)

Developing a Diabetes
• CGM is recommended for persons with T2D who are treated with insulin therapy, or who have high
Mellitus Comprehensive
Care Plan (2022)3 risk for hypoglycemia and/or with hypoglycemia unawareness (Grade A)

All trademarks are the property of their respective owners.

AACE = American Association of Clinical Endocrinology.
*The American Diabetes Association (ADA) recommendations receive a rating of A, B, C, or E depending on the quality and strength of the evidence to support their recommendations. Evidence level A has clear evidence from
well-conducted, generalizable, randomized controlled trials (RCTs) that are adequately powered. Evidence level B has supportive evidence from well-conducted cohort studies. Evidence level C has supportive evidence from poorly
controlled or uncontrolled studies. Evidence Level E is from expert consensus or clinical experience. 4
References: 1. American Diabetes Association. Diabetes Care. 2022;45(Suppl 1):S97-S112. 2. Grunberger G, et al. Endocr Pract. 2021;27(6):505-537. 3. Blonde L, et al. Endocr Pract. 2022;28(10):923-1049. 4. American
Diabetes Association. Diabetes Care. 2022;45(Suppl 1):S1-S2.

13
Continuous Glucose Monitoring
15
G7 Product
Indications | Sensor | Receiver
Compatible Devices, & Apps
Superbowl Ad
Indications and Safety
Indications for Use

Real time continuous glucose monitor (RT-CGM) indicated for

• Persons 2 years and older
• Replacing fingerstick BG testing for treatment decisions
• Autonomously communicating with digitally connected devices,
including autonomously insulin dosing (AID) systems.
• Pregnant women with diabetes
Indications: Where to Insert – Arm or Buttocks

Age 7 years and older: Use back Age 2 - 6 years: Use back of upper arm or
of upper arm upper buttocks
Contraindications

• MRI (magnetic resonance imaging)

• Diathermy (high-frequency electrical heat)
• CT Scan

*However, it's safe to have a CT scan if you

keep the sensor out of the scanned area and
cover the sensor with a lead apron during the
scan.
Warnings

• Do not ignore low/high symptoms

• No number, no arrow, no treatment decision
• Do not use if on dialysis or critically ill
• Contact 24/7 Dexcom technical support if
sensor wire breaks off
• Check sound and Bluetooth settings
Sensor & Transmitter
Dexcom G7 Sensor Packaging

The Dexcom G7 sensor box contains:

• 1 Dexcom G7 10-day applicator
and sensor
• Over patch
• Instructions for use
• No separate transmitter
Applicator and Sensor

What is it?
• Applicator inserts sensor under
the skin
• Every 5 minutes the Applicator
sensor sends a glucose reading
to compatible smart device or
receiver

What does the user do with it? Sensor

• The sensor is worn for up to 10 (inside)
days - plus a 12 hour grace
period
• The sensor and applicator are
thrown away after use
Sensor Insertion Video
Pairing and Sensor Warmup

After entering the pairing code, the user

will wait for sensor to pair.

Once complete the user will enter into the

less than 30-minute sensor warmup.*
Sensor/transmitter Product Specifications

Glucose Range 40–400 mg/dL

Useful Life Up to 10 days - plus a 12-hour grace period

Sterilization Ethylene Oxide gas

Memory Storage Minimum 24 hours of glucose data

Data Backfill for User Display 24 hours

Power Source Internally/battery powered

Battery Longevity (Typical) Sufficient to support 10- day wear period plus a 12-hour grace period

Battery Charging Time Non-rechargeable

Operational Temperature Temperature: 50°F–107.6°F
Operating and Storage Humidity Humidity: 10%–90% RH
Receiver
Dexcom G7 Receiver Packaging

The Dexcom G7 receiver box contains:

• 1 Dexcom G7 Receiver
• USB charger and cable
• Warranty is 1 year
Dexcom G7 Receiver

The Dexcom G7 receiver (receiver), allows users

to view real-time glucose data and trends on a
dedicated medical device.

Now stores 6 months of data!

This training is not inclusive of every feature of the system. For full system information see the Dexcom G7 User Guide.
Receiver Navigation

The receiver screen tells the user

which button to use.
• To scroll faster hold down the
Scroll button
• To move to next field, use the
Select button

Scroll Up
Go Back Select

Scroll Down
Viewing the Receiver Trend Screen

Bluetooth

Battery

Current Glucose Trend Arrow

High Glucose Alert Level Trend Graph

Current Glucose
Low Glucose Alert Level
This training is not inclusive of every feature of the system. For full system information see the Dexcom G6 User Guide.
Compatible Devices & Apps
Compatible Devices

The Dexcom G7 app is available for both Apple

and Android devices.

For compatibility list go to:

dexcom.com/compatibility
Home Screen

Add Event
Current Sensor
Trend Arrow
Reading

Edit High and Low Alert

Hours Shown Level and Turn on/off Quiet
Modes

High Alert Level

Current Sensor Reading

Trend Graph
Low Alert Level (scrub along to view past glucose values)

Clarity Card
Landscape

Click to view 3, 6, 12 or 24 hour trend graph

Insulin
Events
Trend Arrows

Trend arrows show the speed and direction glucose is heading.

Steady Slowly rising or falling Rising or falling Rapidly rising or falling

Changing less Changing Changing Changing more
than 15 mg/dL in 15-30 mg/dL in 30-45 mg/dL in than 45 mg/dL in
15 minutes 15 minutes 15 minutes 15 minutes
High Alert

Alerts when sensor reading is at or

above the set level.

Default: 250 mg/dL

Range: 100-400 mg/dL

Can be turned off or customized

(level, sound/vibrate, delay 1st alert,
snooze) in Profile > Alerts > High
Alert.

Note: Delay 1st Alert is a new

feature to G7. The user can turn on
to delay their first high alert until
their sensor reading is high for a
while. They choose for how long.
Low Alert

Alerts when sensor reading is at or

below the set level.

Default: 70 mg/dL
Range: 60-150 mg/dL

Can be turned off or customized

(level, sound/vibrate, snooze) in
Profile > Alerts > Low Alert.
Urgent Low Alert

Alerts when sensor reading is 55

mg/dL or below.

This alert can’t be changed or turned

off).

After the user acknowledges the first

alert. It repeats if the sensor reading
stays urgently low for 30 minutes. This
setting can’t be changed.

The sound (new sounds added) can

be customized in Profile > Alerts >
Urgent Low.
Urgent Low Soon Alert

Alerts when sensor reading will be

55 mg/dL or below in less than 20
minutes.

Can be turned off or customized

(sound/vibrate, snooze) in Profile
> Alerts > Urgent Low Soon.
Clarity Card

Scroll down in the Glucose tab to see the Clarity

glucose summary reports. The 3, 7, 14, 30, and
90-day reports show glucose changes over time
using the information recorded in the app.
Dexcom Share

Dexcom Share is a feature of the Dexcom G7

app. Dexcom Share lets the user or Sharer
send their Dexcom G7 information to up to 10
Followers.

This training is not inclusive of every feature of the system. For full system information see the Dexcom G7 User Guide.
How Does Dexcom Share Work?

Dexcom Share is a feature within

the Dexcom G7 app that allows
one person, (the Sharer) to
remotely transfer their glucose
information to others (Followers).

The Dexcom Follow app is a FOLL

separate app and is part of OW
Dexcom Share.
Data sent
Add up to 10 followers. securely to Followers

Followers (parents, caregivers, etc.) need

to download the separate Dexcom Follow
app
Accuracy &
Comparisons
MARD | Dexcom G6 | Libre 2 & 3
Accuracy & MARD
Accuracy

You may wonder why the Dexcom G7 reading

doesn’t match the reading provided by a blood
glucose (BG) meter.
What is Mean Absolute Relative Difference (MARD)?

MARD is the average percent difference of the CGM reading compared to the lab result. The lower the
MARD, the more accurate the device. Most BG meters and Dexcom G7, have on average, MARDs
under 10%.

%
CGM Reading Percent difference Lab Result
between the CGM (Known as the “gold
reading and lab result standard” or YSI)
= MARD
G6 Comparisons
Features & Benefits

Dexcom G6 Features Included in Dexcom G7

• No fingerstick, scanning, or calibration required
• Real-time glucose readings sent automatically every 5
minutes to a compatible display device
• Integration with the world's largest connected CGM
ecosystem
• Apple Watch
• Garmin
• Other digital health apps
• Remote monitoring, enabling users to share glucose data
with up to 10 followers
• Proven Dexcom accuracy and performance
• Only CGM to offer a predictive low alert that can recognize
potentially dangerous hypo- incidences before they occur

52
Features & Benefits
New Features with Dexcom G7

• 60% smaller, all-in-one, discreet wearable, easier to use with

fewer components
• 30-minute sensor warmup, fastest of any CGM on the market
• 12-hour grace period to replace finished sensors for a more
seamless transition between sessions
• Redesigned and simplified mobile app with Dexcom Clarity
integration
• Improved alert settings for enhanced discretion
• Redesigned, optional receiver that is smaller with a more vibrant,
easier to read display
• Indicated for wear on the back of the upper arm for ages 2 years
and older or the upper buttocks for ages 2-6 years old
• 24-hour data backfill
• Receiver now stores 6 months of data

53
Comparisons to Competitor
55
56
Questions?